Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

W
Wada, David (Russ)

QuanTx Consulting
(M1230-02-10) No Clinically Meaningful Pharmacokinetic Drug-Drug Interaction Between Berotralstat and the Progestin Oral Contraceptive Desogestrel
David (Russ) Wada
Favorite
Wade, Jonathan

Eli Lilly and Company
(T1030-11-65) Formulation in a Droplet – a Material Sparing Approach to Wet Granulation Formulation Screening
Jonathan Wade
Favorite
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Jonathan Wade
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Jonathan Wade
Favorite
Wadi, Ahmed

University of Mississippi
(T1530-10-55) 3D Printed Container System for Delayed Release
Ahmed Wadi
Favorite
Wagner, Karl

University Bonn
(M1430-10-59) High Drug Load Metformin ER 1000 mg Tablets Processed via Roller Compaction in Combination with High Molecular Weight HPC
Karl Wagner
Favorite
Wahab, Abiodun

University of Alabama
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Abiodun Wahab
Favorite
Wahab, S M Riajul

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
S M Riajul Wahab
Favorite
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
S M Riajul Wahab
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
S M Riajul Wahab
Favorite
Walenga, Ross

US Food and Drug Administration
(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products
Ross Walenga
Favorite
Waller, Mark

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Mark Waller
Favorite
Walsh, Andrew

Corium Innovations
(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery
Andrew Walsh
Favorite
Walsh, Taylor

Eurofins Lancaster Laboratories Professional Scientific Services
(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams
Taylor Walsh
Favorite
Wan, Bo

University of Connecticut
(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres
Bo Wan
Favorite
Wan, Bo

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Bo Wan
Favorite
Wan, Boyong

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Boyong Wan
Favorite
Wang, Ching-Chiung

Taipei Medical University
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Ching-Chiung Wang
Favorite
Wang, Dong

University of Nebraska Medical Center
(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture
Dong Wang
Favorite
Wang, Fei

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Fei Wang
Favorite
(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating
Fei Wang
Favorite
Wang, Fengqiang

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Fengqiang Wang
Favorite
Wang, Honghe

University of Mississippi
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Honghe Wang
Favorite
(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release
Honghe Wang
Favorite
Wang, Hongmei

WuXi AppTec (Shanghai) Co., Ltd.
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Hongmei Wang
Favorite
Wang, Jennie

SRI International
(M1430-10-55) Formulation Development of High Drug Loaded, Stable Amorphous Solid Dispersions (ASDs) Through Spray Drying: An Industrial Perspective Case Study
Jennie Wang
Favorite
Wang, Jessica (Zheng)

Regeneron Pharmaceuticals
(M0930-06-36) 1-Tiered Approach for Anti-drug Antibody Testing in Clinical Study
Jessica (Zheng) Wang
Favorite
Wang, Jiang

US Food and Drug Administration
(M1430-06-35) Avoiding Pitfalls in Selecting Quality Control Concentrations in Surrogate Matrix Approach for Endogenous Drugs
Jiang Wang
Favorite
Wang, Jianxin (Jason)

Resolian
(T0930-06-35) Analysis of Drug-Antibody Ratio (DAR) of ADC (M9346A-SPDB-DM4) in Rabbit Cornea and K₂EDTA Plasma Using SEC-MS
Jianxin (Jason) Wang
Favorite
Wang, Jiawen

Queen's University Belfast
(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis
Jiawen Wang
Favorite
(T0930-04-23) Poly(Acrylic Acid)/Poly(Vinyl Alcohol) Microarray Patches for Continuous Transdermal Delivery of Levodopa and Carbidopa: In Vitro and In Vivo Studies
Jiawen Wang
Favorite
Wang, Jiefei

University of Pittsburgh
(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease
Jiefei Wang
Favorite
Wang, Kaikai

University of Michigan
(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery
Kaikai Wang
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Kaikai Wang
Favorite
Wang, Kelin

Moderna Therapeutics
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Kelin Wang
Favorite
Wang, Lushan

Johnson & Johnson
(W1230-04-24) Disruptions in Glucose and Amyloid-Beta Transport in Mouse Models Manifesting Metabolic Syndrome
Lushan Wang
Favorite
Wang, Miaojun

Applied Materials
(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement
Miaojun Wang
Favorite
Wang, Michael Zhuo

University of Kansas
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Michael Zhuo Wang
Favorite
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Michael Zhuo Wang
Favorite
Wang, Pinger

Janssen Research & Development, LLC
(W1030-11-65) Vicious Variability: Capillary Isoelectric Focusing Method Performance Issues with Non-Detergent Sulfobetaine 211 as an Additive
Pinger Wang
Favorite
Wang, Qi

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Qi Wang
Favorite
Wang, Rong

US Food and Drug Administration
(M1430-02-07) An Overview of Cross-Referencing Approaches to Support Generic Drug Approval
Rong Wang
Favorite
(W1230-02-11) Risk Assessment for Extrapolation of Bioequivalence Conclusion from a Male-Only Study Population to the General Population
Rong Wang
Favorite
Wang, Rui

WuXi AppTec (Shanghai) Co., Ltd.
(W1030-06-36) Development of a Rapid, High Throughput Quantitative Bioanalysis of Conjugated Payloads of Protease-Cleavable Antibody-Drug Conjugate (ADC) in Rat Serum Using Automated Immunocapture Based UPLC-MS/MS
Rui Wang
Favorite
Wang, Ruifeng

University of Connecticut
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Ruifeng Wang
Favorite
wang, Serena

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Serena wang
Favorite
Wang, Shuying

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
Shuying Wang
Favorite
Wang, Sihong

City College of New York
(T0930-06-32) Tumor Chip to Study Dynamics between Immunotherapeutics, Tumor Stroma, and Immune Cells
Sihong Wang
Favorite
Wang, Viola

WuXi AppTec Co., Ltd.
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Viola Wang
Favorite
Wang, Wei

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Wei Wang
Favorite
Wang, Xiaoyi

University of Connecticut
(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants
Xiaoyi Wang
Favorite
Wang, Xinning

Case Western Reserve University
(T1330-06-32) Bombesin-Tagged Nanobubbles as Ultrasound Contrast Agents for Prostate Cancer Diagnosis
Xinning Wang
Favorite
Wang, Xinyao

University of Michigan
(W1030-04-22) Antimicrobial Effects of S-nitrosothiols on Mycobacterium abscessus Biofilms
Xinyao Wang
Favorite
Wang, Xinye

University of Michigan
(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin
Xinye Wang
Favorite
(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System
Xinye Wang
Favorite
Wang, Xuechun

AbbVie Inc.
(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs
Xuechun Wang
Favorite
Wang, Xuefang

WuXi AppTec Co., Ltd.
(W1030-06-31) Comparison of the Performance of Luminex-Based and MSD-Based Immunogenicity Assays for Multivalent HPV Vaccines
Xuefang Wang
Favorite
Wang, Xuejing Aimee

Eli Lilly and Company
(T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
Xuejing Aimee Wang
Favorite
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Xuejing Aimee Wang
Favorite
Wang, Yan

US Food and Drug Administration
(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release
Yan Wang
Favorite
(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant
Yan Wang
Favorite
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Yan Wang
Favorite
(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits
Yan Wang
Favorite
(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products
Yan Wang
Favorite
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Yan Wang
Favorite
Wang, Yi

University of Connecticut
(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions
Yi Wang
Favorite
Wang, Yifan

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Yifan Wang
Favorite
Wang, Yihan

University of Maryland Baltimore
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Yihan Wang
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Yihan Wang
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Yihan Wang
Favorite
Wang, ying

University of Michigan
(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity
ying Wang
Favorite
Wang, Yinghe

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Yinghe Wang
Favorite
Wang, Zhaoxian (George)

Bristol-Myers Squibb Company
(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs
Zhaoxian (George) Wang
Favorite
Wang, Zhengqiang

University of Minnesota
(W1130-04-19) GSH-Dependent Inhibition of Multidrug Resistance-Associated Protein 1 (MRP1) by ZW-1226
Zhengqiang Wang
Favorite
Wang, Zhihui

Houston Methodist Research Institute
(T1030-02-10) Modeling-Derived Immune Signature Explains Population-Scale Variability in Vaccine-Induced Immune Response
Zhihui Wang
Favorite
(W1030-02-09) Machine Learning-Based Rational Design of Inorganic Nanoparticles for Improved Safety in Biomedical Applications
Zhihui Wang
Favorite
Wang, Zijian

University of Minnesota
(T0930-05-25) Impact of Excipient Types and Drug Loadings on the Tabletability Flip Phenomenon
Zijian Wang
Favorite
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Zijian Wang
Favorite
Wani, Shweta

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Shweta Wani
Favorite
Waranuch, Neti

Naresuan University
(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention
Neti Waranuch
Favorite
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Neti Waranuch
Favorite
Warren, Brandon

University of Florida
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Brandon Warren
Favorite
Warunek, Jordan

University of Pittsburgh
(M1230-06-31) Manipulating the PLGA Terminal Group Chemistry Alters Electrostatic Controlled Release from Polymeric Microparticles
Jordan Warunek
Favorite
Wasalathanthri, Dhanuka

Bristol Myers Squibb Company
(T0930-11-60) Rapid Total Sialic Acid Monitoring During Cell Culture Process Using a Machine Learning Model Based Soft Sensor
Dhanuka Wasalathanthri
Favorite
Watson, Thomas

International Flavors and Fragrances
(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications
Thomas Watson
Favorite
Watson, Tom

International Flavors and Fragrances
(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin
Tom Watson
Favorite
Watt, Kevin

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Kevin Watt
Favorite
Watts, Alan

Catalent, Inc.
(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer
Alan Watts
Favorite
Weaver, Lauren

i2Vision
(T1030-04-23) Clinical Potential of UK4b as a New Generation of Anti-Inflammatory Drug to Treat Pain and Arthritis
Lauren Weaver
Favorite
(T1530-04-20) Anti-inflammatory and Analgesic Effects of Lapatinib in Rats
Lauren Weaver
Favorite
Webster, Jarom

Thermo Fisher Scientific
(M1330-11-65) Compression Process Optimzation Using 2³ Full Factorial Design of Experiments
Jarom Webster
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Jarom Webster
Favorite
Webster, Thomas M.

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Thomas M. Webster
Favorite
Wei, Huimei

University of Kentucky
(M0930-04-22) A Catalytic Aldicarb Bioscavenger as a Treatment for Aldicarb Poisoning
Huimei Wei
Favorite
(T0930-02-10) PK/PD Relationship of a Promising Protein Drug Candidate (CocH5-Fc(M6)) and Its Efficacy in Blocking Cocaine Discrimination in Rats
Huimei Wei
Favorite
Wei, Kevin

US Food and Drug Administration
(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions
Kevin Wei
Favorite
Weissig, Volkmar

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Volkmar Weissig
Favorite
Welch, Jonathan

Merck & Co., Inc.
(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development
Jonathan Welch
Favorite
Welch, Katie

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Katie Welch
Favorite
Wen, Xinxin

WuXi AppTec (Shanghai) Co., Ltd.
(M1030-06-36) Simultaneous Determination of Metabolites from Seven Key Probe Substrates in CYP Inhibition Assay Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Xinxin Wen
Favorite
Westlund, Karin N

University of New Mexico
(T1130-06-32) Humanized scFv Antibody Specific to an Extracellular Epitope of CCK-BR and Non-Opioid Therapies for Pain Management
Karin N Westlund
Favorite
Wetzel, Stefan

IntiQuan AG
(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch
Stefan Wetzel
Favorite
Whang, Dakyung

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Dakyung Whang
Favorite
Whelihan, Matt

Prolytix
(T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug
Matt Whelihan
Favorite
White, Andrew

UK Health Security Agency
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Andrew White
Favorite
White, Brianna

Emery Pharma
(W0930-06-36) ICH M10 Bioanalytical Method Validation for Quantitation of Ketorolac in Human Vitreous and Aqueous Humor using Human Plasma as a Surrogate Matrix
Brianna White
Favorite
Wijewantha, Nisitha

US Food and Drug Administration
(T1030-11-61) Comprehensive Composition Analysis of Doxorubicin HCl Liposomes
Nisitha Wijewantha
Favorite
Wilcock, Brandon

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Brandon Wilcock
Favorite
(M1330-02-10) Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid: A Novel Approach for Biomarker Analysis
Brandon Wilcock
Favorite
Wildfong, Peter L.D.

Duquesne University
(M1530-07-39) Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions
Peter L.D. Wildfong
Favorite
(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying
Peter L.D. Wildfong
Favorite
(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used
Peter L.D. Wildfong
Favorite
Wilkie, Emma

Solid State Pharma Inc.
(W1230-04-22) Assessment of High Throughput Salt Screening Methodologies with Zwitterionic Compounds
Emma Wilkie
Favorite
Willett, Daniel

US Food and Drug Administration
(T1230-11-63) Laser Directed Infrared (LDIR) Imaging to Track the Evolution of Polymorphic Transformation During Stability Studies on Ritonavir Tablets
Daniel Willett
Favorite
Williams, Mark

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Mark Williams
Favorite
Williams, Michael

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Michael Williams
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Michael Williams
Favorite
Williamson, Jeff

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Jeff Williamson
Favorite
(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation
Jeff Williamson
Favorite
(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study
Jeff Williamson
Favorite
Williams, Robert

The University of Texas at Austin
(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing
Robert Williams
Favorite
(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying
Robert Williams
Favorite
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Robert Williams
Favorite
(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying
Robert Williams
Favorite
Williams, Steve

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Steve Williams
Favorite
Williams, Steve

Centre for Biopharmaceutical Excellence Pty Ltd
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Steve Williams
Favorite
Williard, Clark

Syneos Health
(W0930-06-32) A Sensitive Method for the Detection and Quantitation of Nalmefene in Human Plasma Samples for Pharmacokinetic Analysis
Clark Williard
Favorite
Wilson, Ian

Imperial College London
(M1330-06-33) Plasma and Liver Pharmacolipidodynamics of Gefitinib after Intravenous Administration to Mice Using LC-MS/MS and MS Imaging
Ian Wilson
Favorite
(T1430-06-33) Comparison of the Pharmacokinetics and Metabolic Fate of Gefitinib – 3 – PROTACs and Gefitinib in the Rat Following Subcutaneous Dosing
Ian Wilson
Favorite
Wilson, Peter

Queen's University Belfast
(W1030-11-62) Production of Drug Nanocrystals Using a Cost-Effective Miniaturised Media Milling Approach
Peter Wilson
Favorite
Wilson, Renae

Nova Southeastern University
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Renae Wilson
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Renae Wilson
Favorite
Winiarski, Maciej

Institute of Low Temperature and Structure Research
(M0930-02-09) Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data
Maciej Winiarski
Favorite
Wisniewski, Steven

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Steven Wisniewski
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Steven Wisniewski
Favorite
Wi, Sungsool

National High Magnetic Field Laboratory
(T0930-11-63) Solid-State NMR and FTIR Reveal Moisture-Triggered Adhesion Loss in Rotigotine Patches
Sungsool Wi
Favorite
Wohlstadter, Jacob

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Jacob Wohlstadter
Favorite
Won, Donghan

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Donghan Won
Favorite
Wong, Li Chin

Eli Lilly and Company
(W0930-10-55) Development of a Sensitive, Drug Tolerant Total Antibody Assay for the Detection of Antibodies against a Novel Capsid AAVPRV in Human Serum and CSF
Li Chin Wong
Favorite
Wong, Melissa

dsm-firmenich
(M1430-04-19) Discovery of BB99: A Potent T2R54 (TAS2R39) Antagonist that Blocks the Bitterness of Select Active Pharmaceutical Ingredients (APIs)
Melissa Wong
Favorite
Wong, Norris

Waters Corporation
(M1230-11-61) Development of Improved Chromatographic Methods for the Separation of Synthetic Peptide Medications and Associated Impurities
Norris Wong
Favorite
(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration
Norris Wong
Favorite
Wong, Siu Ming Raymond

Prince of Wales Hospital, Hospital Authority
(T1230-02-07) Risk-Based Decision Matrix for Identification of High-Risk Pharmaceutical Products that Need a Full-Scale Toxicological Evaluation
Siu Ming Raymond Wong
Favorite
Wong, Timothy

Resolian
(W1030-06-32) An Electrochemiluminescence (ECL)-Based Assay for the Specific Detection of Neutralizing Anti-CAEL-01 Antibodies in Human Serum with a Pre-Treatment Procedure to Eliminate Therapeutic Drug
Timothy Wong
Favorite
Wongumpornpinit, Vorawut

Naresuan University
(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin
Vorawut Wongumpornpinit
Favorite
Wood, Brent

NanoImaging Services
(W1130-11-60) Using Cryo-TEM to Characterize Structural Details of LNPs During Manufacturing
Brent Wood
Favorite
Wood, Jason

BASF Corporation
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Jason Wood
Favorite
(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient
Jason Wood
Favorite
(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations
Jason Wood
Favorite
(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System
Jason Wood
Favorite
Woods, Adam

BASF Corporation
(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study
Adam Woods
Favorite
Wood, Sharla

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Sharla Wood
Favorite
Wood, Tim

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Tim Wood
Favorite
Woo, Mi Ran

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Mi Ran Woo
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Mi Ran Woo
Favorite
Woo, Sanghyun

Hanyang University
(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sanghyun Woo
Favorite
(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib
Sanghyun Woo
Favorite
Woo, Sukyung

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Sukyung Woo
Favorite
Worrest, Hannah

Lonza
(M1430-10-56) Material Sparing Dry Granulation via RoCo Simulation Enables Technical Transfer of SDI-Based Formulations
Hannah Worrest
Favorite
Wo, Siu Kwan

Chinese University of Hong Kong, The
(T1330-02-10) Genetic Polymorphism Based Inhibition on CYP450 by Radix Puerariae lobatae in Healthy Subjects
Siu Kwan Wo
Favorite
Wrona, Mark

Waters Corporation
(M1430-11-64) System Robustness and Best Practices of a High Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis
Mark Wrona
Favorite
Wu, Fang

US Food and Drug Administration
(M1530-04-23) Deciphering Sub-Therapeutic Risks: Integrating In Vitro Release and Modeling for Lamotrigine Extended-Release Tablets
Fang Wu
Favorite
(T1230-04-23) PBPK Modeling to Predict the Effect of Gastric pH on Bioequivalence of Dabigatran Etexilate Capsules
Fang Wu
Favorite
(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product
Fang Wu
Favorite
Wu, Jiewei

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Jiewei Wu
Favorite
Wu, Jincao

Eisai Inc.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Jincao Wu
Favorite
Wu, Qi

Moderna, Inc.
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Qi Wu
Favorite
Wu, Xiangmeng

University of Arizona
(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites
Xiangmeng Wu
Favorite
Wu, Xiaohuan

Foghorn Therapeutics
(M1030-11-65) Characterization of Long-Acting Injectable Formulation for Pre-Clinical Studies Using Accelerated In Vitro Release (IVR) Technique
Xiaohuan Wu
Favorite
(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders
Xiaohuan Wu
Favorite
Wu, Yanyuan

Charles Drew University of Medicine and Science
(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro
Yanyuan Wu
Favorite
Wu, Yue

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Yue Wu
Favorite